CINCINNATI--(BUSINESS WIRE)--Sept. 23, 2004--Meridian Bioscience,
Inc. (Nasdaq:VIVO) today announced that the Company has been invited
to present at the UBS Global Life Science Conference, Wednesday,
September 29, 2004 at 4:30 p.m. EDT at the Grand Hyatt New York in New
York City. Jack Kraeutler, President and Chief Operating Officer, has
been scheduled to present. A question and answer session will follow
and some of the information provided during the session may not have
been previously disclosed. Mr. Kraeutler will be available to meet
with investors during the Conference.
Meridian invites investors to listen to management's remarks, over
the internet, on the Company's website at www.meridianbioscience.com.
The archived broadcast will be available until October 30, 2004.
Meridian is a fully integrated life science company that
manufactures, markets and distributes a broad range of innovative
diagnostic test kits, purified reagents and related products and
offers biopharmaceutical enabling technologies. Utilizing a variety of
methods, these products provide accuracy, simplicity and speed in the
early diagnosis and treatment of common medical conditions, such as
gastrointestinal, viral, urinary and respiratory infections. All
Meridian diagnostic products are used outside of the human body and
require little or no special equipment. The Company's products are
designed to enhance patient well-being while reducing the total
outcome costs of healthcare. Meridian has strong market positions in
the areas of gastrointestinal and upper respiratory infections,
serology, parasitology and fungal disease diagnosis. In addition,
Meridian is a supplier of rare reagents and specialty biologicals
along with proteins and other biologicals used by biopharmaceutical
companies engaged in research for new drugs and vaccines. The Company
markets its products to hospitals, reference laboratories, research
centers, veterinary testing centers, physician offices and diagnostics
manufacturers in more than 60 countries around the world. The
Company's shares are traded through Nasdaq's National Market, symbol
VIVO. Meridian's website address is www.meridianbioscience.com.
CONTACT: Meridian Bioscience, Inc., Cincinnati
John A. Kraeutler, 513-271-3700
SOURCE: Meridian Bioscience, Inc.
